In 1995, there will be 172 000 new cases of lung cancer diagnosed and
153 000 deaths from this disease in the United States. While the patho
genesis of the disease profess is poorly understood, a growing body of
evidence suggests that abnormalities in cellular regulatory genes may
play an important role in the induction, maintenance and/or progressi
on of some tumor types. These genes include both growth promoting onco
genes as well as growth inhibitory or suppressor genes. Included among
these genetic sequences are several cellular transcription factor. A
group of these factors including c-jun, c-fos and EGR1 are members of
a class of genes known as immediate early genes whose expression are i
nducible by a variety of stimuli including mitogenic and differentiati
on inducing growth factors, indicating a potential important role for
these genes in normal growth processes. Since these genes are involved
in early regulation of cellular growth properties and at least two (c
-jun and c-fos) can act as oncogenes, we wished to determine whether t
heir expression levels were altered in human non-small cell lung cance
rs (NSCLC) compared to normal lung tissue. To address this, Northern b
lot analyses were performed using c-fos, c-jun and EGR1 probes on RNA
extracted from 101 NSCLC tumor specimens and adjacent uninvolved lung
tissue. Analysis of this cohort revealed that 72% of the normal tissue
s demonstrate significantly greater expression of these transcription
factors as compared to adjacent malignant tissue. Moreover, this expre
ssion pattern appeared to be coordinate for all three genes in the maj
ority of cases. This differential expression pattern was confirmed at
the protein level using an immunohistochemical approach with antibodie
s directed against the c-jun, c-fos and EGR1 gene products. Southern b
lot analyses demonstrated no gross alterations of these sequences at t
he DNA level, indicating that the observed differential expression pat
tern was not due to gross structural changes in the genes. These data
suggest that downregulation of these genes may be involved in the path
ogenesis of lung cancer.